You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

inflammasome

Showing 26 - 50 of 249
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Level, Symptoms, and Functional Status in HFpEF Patients Treated

Unknown status
  • Heart Failure
    • Chongqing, China
      The First Affiliated Hospital of Chongqing Medical University
    Feb 12, 2020

    Type 2 Diabetes, Insulin Sensitivity/Resistance, Inflammatory Response Trial (Omega-3 fatty acids (2.7 g/d, EPA:DHA, 2:1))

    Completed
    • Type 2 Diabetes
    • +3 more
    • Omega-3 fatty acids (2.7 g/d, EPA:DHA, 2:1)
    • (no location specified)
    Aug 3, 2020

    Osteoarthritis Trial (Quercetin Cap/Tab ,Fisetin Cap/Tab, Quercetin Cap/Tab,Fisetin Cap/tab,Glycyrrhizin capsules, Placebo)

    Not yet recruiting
    • Osteoarthritis
    • Quercetin and Fisetin tab.
    • +2 more
    • (no location specified)
    Jan 18, 2023

    Lupus Nephritis, SLE Nephritis Trial (Curcumin Oral Capsule)

    Not yet recruiting
    • Lupus Nephritis
    • SLE Nephritis
    • Curcumin Oral Capsule
    • (no location specified)
    Feb 3, 2023

    Metabolic Syndrome, Cardiovascular Risk Factor Trial in Athens (Probiotic mix, Placebo)

    Withdrawn
    • Metabolic Syndrome
    • Cardiovascular Risk Factor
    • Probiotic mix
    • Placebo
    • Athens, Greece
      Attikon University General Hospital
    Mar 30, 2022

    Chronic Kidney Diseases, Peritoneal Dialysis, Hemodialysis Trial in Rio de Janeiro (Curcumin supplementation)

    Recruiting
    • Chronic Kidney Diseases
    • +2 more
    • Curcumin supplementation
    • Rio de Janeiro, RJ, Brazil
      Denise Mafra
    Jan 4, 2022

    Inflammatory and Coagulation in SAH CSF

    Completed
    • Subarachnoid Hemorrhage, Aneurysmal
    • Lumbar puncture
    • Hangzhou, Zhejiang, China
      Second affiliated hosipital of zhejiang univerisity school of me
    Dec 15, 2021

    Characterization of Treatment Responses in Lymphedema

    Suspended
    • Lymphedema
    • Stanford, California
      Stanford University
    Aug 4, 2022

    Acute Coronary Syndrome, Myocardial Ischemia Trial in Roma (Anamnesis and clinical evaluation)

    Recruiting
    • Acute Coronary Syndrome
    • Myocardial Ischemia
    • Anamnesis and clinical evaluation
    • Roma, Lazio, Italy
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS di R
    Mar 3, 2023

    Mitochondrial Dysfunction in Occurrence of Acute Kidney Injury

    Completed
    • Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery Requiring Extracorporeal Circulation
    • Coronary Artery Bypass Graft (CABG)
    • Fort-de-France, France
      CHU de Martinique
    Feb 22, 2022

    Healthy Trial in Ahmedabad (ZYIL1 Capsule)

    Completed
    • Healthy
    • ZYIL1 Capsule
    • Ahmedabad, Gujarat, India
      Zydus Research Centre
    Nov 15, 2021

    Tetracycline to Limit Innate Immune Response in Acute

    Unknown status
    • Adult Respiratory Distress Syndrome
    • +2 more
    • Sampling of Blood and bronchoalveolar lavage
    • Bonn, Germany
      University Hospital Bonn
    Sep 3, 2019

    INFLAmmasomes NLRP3 in Platelets and Leukocytes During SEPSIS in

    Recruiting
    • Sepsis
    • Blood collection
    • Toulouse, France
      University Hospital of Toulouse
    Jun 8, 2022

    NMO Spectrum Disorder, Azathioprine Adverse Reaction Trial in Nanning (Azathioprine)

    Completed
    • NMO Spectrum Disorder
    • Azathioprine Adverse Reaction
    • Nanning, Guangxi, China
      Qingmeng Huang
    Jun 8, 2023

    Myocardial Dysfunction, Heart Failure, Inflammation Trial run by the NHLBI (Dapagliflozin, MRI scan, CMR imaging)

    Withdrawn
    • Myocardial Dysfunction
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jun 23, 2022

    Systemic Lupus Erythematosus Trial in Vandoeuvre les nancy

    Not yet recruiting
    • Systemic Lupus Erythematosus
      • Vandoeuvre les nancy, Lorraine, France
        Thomas Moulinet
      Jun 15, 2022

      Environmental Mycobiota: In-depth Characterisation and

      Not yet recruiting
      • Asthma
      • Assessment of the microbial exposome
      • Bourdeaux, France
      • +1 more
      Apr 4, 2023

      Inflammatory Response, Muscular Injury Trial in Kannapolis (Mangoes, Water)

      Recruiting
      • Inflammatory Response
      • Muscular Injury
      • Mangoes
      • Water
      • Kannapolis, North Carolina
        Appalachian State University Human Performance Lab, North Caroli
      Oct 24, 2022

      COVID-19 Pneumonia Trial in Doha (Colchicine)

      Recruiting
      • COVID-19 Pneumonia
      • Doha, DA, Qatar
        Alaa Rahal
      Nov 22, 2021

      Extremes of Coronary Artery Disease and Normality:CAD Extremes

      Not yet recruiting
      • Coronary Artery Disease
      • Blood draw
      • (no location specified)
      Mar 7, 2023

      A Diagnostic Test for Familial Mediterranean Fever

      Completed
      • Familial Mediterranean Fever
      • In vitro functional test
      • Bron, France
      • +3 more
      Jun 7, 2021

      Familial Mediterranean Fever Trial in Nîmes, Paris, Toulouse (Blood sampling)

      Not yet recruiting
      • Familial Mediterranean Fever
      • Blood sampling
      • Nîmes, France
      • +3 more
      Sep 12, 2023

      Personalized Signature of Chronic Inflammation and Early Aging

      Recruiting
      • Male Infertility
      • Collection of clinical and biological material
      • Milan, Lombardy, Italy
        IRCCS Ospedale San Raffaele
      Oct 9, 2023

      NLRP3 Inflammasome in Escherichia Coli and Staphylococcus Aureus

      Unknown status
      • Escherichia Coli Infections
      • Staphylococcus Aureus
      • Sample analysis
      • Antibes, France
      • +2 more
      Mar 7, 2019

      Heart Failure, Heart Failure With Reduced Ejection Fraction (HFrEF) Trial in Salt Lake City (Vericiguat, Placebo)

      Not yet recruiting
      • Heart Failure
      • Heart Failure With Reduced Ejection Fraction (HFrEF)
      • Salt Lake City, Utah
      • +1 more
      Dec 28, 2022